SAN

82.48

+0.01%↑

MRK1

112.3

+0.36%↑

SHL.DE

46.8

-0.28%↓

ARGX

478.8

+0.23%↑

FRE

42.51

+0.83%↑

SAN

82.48

+0.01%↑

MRK1

112.3

+0.36%↑

SHL.DE

46.8

-0.28%↓

ARGX

478.8

+0.23%↑

FRE

42.51

+0.83%↑

SAN

82.48

+0.01%↑

MRK1

112.3

+0.36%↑

SHL.DE

46.8

-0.28%↓

ARGX

478.8

+0.23%↑

FRE

42.51

+0.83%↑

SAN

82.48

+0.01%↑

MRK1

112.3

+0.36%↑

SHL.DE

46.8

-0.28%↓

ARGX

478.8

+0.23%↑

FRE

42.51

+0.83%↑

SAN

82.48

+0.01%↑

MRK1

112.3

+0.36%↑

SHL.DE

46.8

-0.28%↓

ARGX

478.8

+0.23%↑

FRE

42.51

+0.83%↑

Search

Almirall SA

Suletud

SektorTervishoid

10.64 -1.3

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.64

Max

10.78

Põhinäitajad

By Trading Economics

Sissetulek

24M

22M

Müük

28M

286M

P/E

Sektori keskmine

96.546

50.291

Aktsiakasum

0.1

Dividenditootlus

1.73

Kasumimarginaal

7.55

Töötajad

2,026

EBITDA

3.9M

45M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+13.85% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.73%

2.40%

Järgmine tulemuste avaldamine

25. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

347M

2.3B

Eelmine avamishind

11.94

Eelmine sulgemishind

10.64

Uudiste sentiment

By Acuity

50%

50%

162 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Almirall SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. dets 2024, 07:05 UTC

Market Talk

EU Specialty Pharma to See Product Launches But Limited Clinical Data Next Year -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Almirall SA Prognoos

Hinnasiht

By TipRanks

13.85% tõus

12 kuu keskmine prognoos

Keskmine 12.25 EUR  13.85%

Kõrge 12.5 EUR

Madal 12 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Almirall SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.76 / 10.2Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

162 / 380 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Almirall SA

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.